Article thumbnail

PRM23 Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales

By C. Righetti, M. Lebmeier, B. Pennington and N.J. Brereton
Publisher: Published by Elsevier Inc.
Year: 2013
DOI identifier: 10.1016/j.jval.2013.08.1576
OAI identifier:

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.